概述
Your teams understand the science. What they don’t have is a straight line from question to answer. The reason is development’s outdated “operating system.”Data lives in disconnected systems, so that every new analysis triggers a new integration project. AI pilots stall because outputs can’t be reproduced, audited, or defended in a regulatory submission. And the manual handoffs between discovery, clinical, and regulatory compound the cost of every delay.
Today, drug development gets a new OS. Certara NEXUS™ is Certara’s integrated platform for efficient drug discovery, development, and submission — bringing Certara’s applications, your data, and governed agentic AI into one connected environment. By orchestrating tool collaboration across your workflows, teams work from a single source of scientific truth, from discovery to submission.
Join us for the public debut of Certara NEXUS, where our leadership team will walk through the platform, explore use cases, and show how scientific and business leaders are already moving from siloed processes to connected, repeatable execution — with the traceability regulators require.
点击报名
James Blauvelt
Director, AI and Data Sciences, CertaraJames Blauvelt is Director, AI and Data Sciences at Certara, where he builds and leads the data science and machine learning engineering teams behind Certara’s AI platform. A driven, curious leader in data science and generative AI, James has more than a decade of experience leading high-velocity teams and developing natural language processing and other deep learning systems. Prior to Certara, he built scalable deep learning and NLP systems at Vyasa Analytics until its acquisition by Certara. James holds a Master of Science in Data Science and Analytics from the University of New Hampshire and resides in Dover, New Hampshire.
Nick Brown
Director, Global Portfolio Leader for Certara.AINick Brown 是生命科学专业 GPT 平台 Certara.AI 的全球投资组合总监。Nick 在推动生命科学、联邦政府和其他行业的人工智能应用和客户成功方面拥有超过 10 年的经验。在加入 Certara 之前，Nick 在 Vyasa（现为 Certara.AI）领导营销工作，协助 Layar 数据平台的发布和市场推广战略。他毕业于新罕布什尔大学，现居住在马萨诸塞州安多弗市。
Adrian Stevens
Chief Product Officer, ChemaxonAdrian Stevens joined Chemaxon as Chief Product Officer in 2022. Adrian has spent approximately 15 years working in Life Sciences software companies, in product management roles for most of his time. As a computational chemist at BioFocus PLC, over the course of nearly 10 years, he supported a wide range of areas in therapeutic research, from oncology, metabolic diseases, autoimmune and pain-based medicines. Adrian has a PhD in Computational Chemistry from the University of Portsmouth.
点击报名
